Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA Return on Capital Employed (ROCE) for the year ending December 31, 2023: 10.65%

Evrofarma SA Return on Capital Employed (ROCE) is 10.65% for the year ending December 31, 2023, a 59.33% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Evrofarma SA Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 6.68%, a 951.07% change year over year.
Evrofarma SA Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 0.64%, a -88.85% change year over year.
Evrofarma SA Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 5.70%, a -0.75% change year over year.
Evrofarma SA Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 5.75%, a -23.06% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumers Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years